Open-Label, Non Randomized Phase 2 Study With Safety Run-In

Clinical trial NCT02249429 · COMPLETED

Trial details

NCT number: NCT02249429
Sponsor: PIQUR Therapeutics AG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Malignant

Start date: 2015-05-01
Primary completion: 2018-09-11
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.